USD 0.59
(-8.8%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.23 Million USD | -152.17% |
2022 | 9.93 Million USD | -89.88% |
2021 | 76.43 Million USD | 176.3% |
2020 | 27.16 Million USD | 550.66% |
2019 | 4.17 Million USD | 859.42% |
2018 | -289.25 Thousand USD | 80.9% |
2017 | -2.87 Million USD | -33.76% |
2016 | -2.6 Million USD | 7.45% |
2015 | 5.4 Million USD | -121.58% |
2014 | -1.04 Million USD | 77.23% |
2013 | -4.6 Million USD | -80.28% |
2012 | -2.55 Million USD | 5.87% |
2011 | 2.98 Million USD | 44.2% |
2010 | 4.04 Million USD | 47.37% |
2009 | -11.84 Million USD | -12.88% |
2008 | -8.19 Million USD | 3.8% |
2007 | -6.66 Million USD | -61.04% |
2006 | -3.31 Million USD | -250.24% |
2005 | -137.09 Thousand USD | 98.14% |
2004 | -7.99 Million USD | -340.3% |
2003 | -4.59 Million USD | -938.72% |
2002 | -4.57 Million USD | 67.77% |
2001 | -5.51 Million USD | 35.6% |
2000 | -8.56 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -3.87 Million USD | -261.44% |
2024 Q1 | -1.09 Million USD | 44.05% |
2023 Q4 | -1.07 Million USD | -133.46% |
2023 Q2 | -1.39 Million USD | -244.3% |
2023 FY | - USD | -152.17% |
2023 Q1 | 966.09 Thousand USD | 121.37% |
2023 Q3 | 3.22 Million USD | 331.14% |
2022 Q1 | 10.81 Million USD | -63.07% |
2022 Q4 | -4.52 Million USD | -404.73% |
2022 FY | - USD | -89.88% |
2022 Q3 | 1.48 Million USD | 912.26% |
2022 Q2 | -182.66 Thousand USD | -101.69% |
2021 Q2 | 13.03 Million USD | -47.51% |
2021 FY | - USD | 176.3% |
2021 Q4 | 29.27 Million USD | 255.41% |
2021 Q3 | 8.23 Million USD | -36.78% |
2021 Q1 | 24.82 Million USD | 78.98% |
2020 FY | - USD | 550.66% |
2020 Q1 | 691.08 Thousand USD | -67.23% |
2020 Q2 | 2.27 Million USD | 229.8% |
2020 Q3 | 10.55 Million USD | 363.01% |
2020 Q4 | 13.87 Million USD | 31.44% |
2019 Q4 | 2.1 Million USD | 64.28% |
2019 FY | - USD | 859.42% |
2019 Q1 | 128.4 Thousand USD | 35.29% |
2019 Q2 | 654 Thousand USD | 409.32% |
2019 Q3 | 1.28 Million USD | 96.29% |
2018 Q2 | -680.95 Thousand USD | -774.31% |
2018 Q1 | 100.98 Thousand USD | 109.75% |
2018 FY | - USD | 80.9% |
2018 Q4 | 94.91 Thousand USD | -51.53% |
2018 Q3 | 195.8 Thousand USD | 128.75% |
2017 Q3 | 185.09 Thousand USD | 116.94% |
2017 Q2 | -1.09 Million USD | -16.94% |
2017 Q1 | -934.6 Thousand USD | 45.61% |
2017 FY | - USD | -33.76% |
2017 Q4 | -1.03 Million USD | -659.43% |
2016 FY | - USD | 7.45% |
2016 Q4 | -1.71 Million USD | -1227.69% |
2016 Q3 | 152.37 Thousand USD | 142.68% |
2016 Q2 | -356.97 Thousand USD | 47.87% |
2016 Q1 | -684.72 Thousand USD | -4.44% |
2015 Q1 | -662.65 Thousand USD | -166.36% |
2015 FY | - USD | -121.58% |
2015 Q4 | -655.64 Thousand USD | -4031.17% |
2015 Q3 | 16.67 Thousand USD | 101.03% |
2015 Q2 | -1.61 Million USD | -144.31% |
2014 Q3 | 668.47 Thousand USD | 162.87% |
2014 Q2 | -1.06 Million USD | 35.67% |
2014 FY | - USD | 77.23% |
2014 Q1 | -1.65 Million USD | -62.91% |
2014 Q4 | 998.51 Thousand USD | 49.37% |
2013 FY | - USD | -80.28% |
2013 Q4 | -1.01 Million USD | -107.37% |
2013 Q3 | -489.25 Thousand USD | 76.28% |
2013 Q2 | -2.06 Million USD | -98.08% |
2013 Q1 | -1.04 Million USD | 52.41% |
2012 Q4 | -2.18 Million USD | -1914.77% |
2012 Q3 | 120.59 Thousand USD | 165.64% |
2012 FY | - USD | 5.87% |
2012 Q2 | -183.7 Thousand USD | 39.65% |
2012 Q1 | -304.42 Thousand USD | 88.46% |
2011 Q2 | -643.23 Thousand USD | -364.0% |
2011 Q1 | 243.64 Thousand USD | 113.12% |
2011 FY | - USD | 44.2% |
2011 Q4 | -2.63 Million USD | -920.47% |
2011 Q3 | 321.44 Thousand USD | 149.97% |
2010 Q2 | -2.66 Million USD | -52.53% |
2010 Q1 | -1.74 Million USD | 32.86% |
2010 Q4 | -1.85 Million USD | -232.08% |
2010 FY | - USD | 47.37% |
2010 Q3 | 1.4 Million USD | 152.7% |
2009 FY | - USD | -12.88% |
2009 Q4 | -2.6 Million USD | 16.88% |
2009 Q2 | -2.43 Million USD | 33.71% |
2009 Q1 | -3.67 Million USD | -25.2% |
2009 Q3 | -3.13 Million USD | -28.79% |
2008 Q1 | -2.72 Million USD | -10.56% |
2008 FY | - USD | 3.8% |
2008 Q4 | -2.93 Million USD | -60.0% |
2008 Q3 | -1.83 Million USD | -160.85% |
2008 Q2 | -702.43 Thousand USD | 74.23% |
2007 Q4 | -2.46 Million USD | -18.86% |
2007 Q1 | -2.37 Million USD | -6.42% |
2007 FY | - USD | -61.04% |
2007 Q3 | -2.07 Million USD | -29.65% |
2007 Q2 | -1.59 Million USD | 32.7% |
2006 Q4 | -2.23 Million USD | -23.88% |
2006 Q3 | -1.8 Million USD | -404.06% |
2006 Q2 | -357.69 Thousand USD | 59.97% |
2006 Q1 | -893.66 Thousand USD | -294.1% |
2006 FY | - USD | -250.24% |
2005 Q1 | -672.17 Thousand USD | 71.21% |
2005 Q2 | -1.48 Million USD | -120.4% |
2005 Q3 | 183.41 Thousand USD | 112.38% |
2005 FY | - USD | 98.14% |
2005 Q4 | 460.41 Thousand USD | 151.02% |
2004 FY | - USD | -340.3% |
2004 Q2 | -11.29 Million USD | -556.6% |
2004 Q1 | -1.72 Million USD | -85.69% |
2004 Q4 | -2.33 Million USD | 96.46% |
2004 Q3 | -65.98 Million USD | -484.0% |
2003 FY | - USD | -938.72% |
2003 Q3 | -1.55 Million USD | 90.11% |
2003 Q4 | -926.7 Thousand USD | 40.45% |
2003 Q1 | -251.78 Thousand USD | -167.64% |
2003 Q2 | -1.85 Million USD | -6151.05% |
2002 Q4 | 372.25 Thousand USD | 130.15% |
2002 Q3 | -1.23 Million USD | -1915.15% |
2002 Q2 | -2.86 Million USD | 83.59% |
2002 Q1 | -373.31 Thousand USD | 57.83% |
2002 FY | - USD | 67.77% |
2001 FY | - USD | 35.6% |
2001 Q2 | -589.19 Thousand USD | 67.12% |
2001 Q3 | -2.25 Million USD | -190.36% |
2001 Q4 | -885.22 Thousand USD | 48.26% |
2001 Q1 | -1.79 Million USD | 28.6% |
2000 Q4 | -2.5 Million USD | 5.84% |
2000 FY | - USD | 0.0% |
2000 Q3 | -2.66 Million USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
InfuSystem Holdings, Inc. | 16.59 Million USD | 107.452% |
Milestone Scientific Inc. | -6.95 Million USD | 82.219% |
Stereotaxis, Inc. | -21.24 Million USD | 94.178% |